Pipeline Overview
Candidate
Mechanism
Mechanism
Target & Lead Discovery
Lead Optimization
IND-Enabling
Phase 1/2
Phase 3
Clinical Program
RBN-2397
PARP7 Inhibitor
PARP7 Inhibitor
Status: Phase: 1
RBN-3143
PARP14 Inhibitor
PARP14 Inhibitor
Status: Phase: IND-Enabling
Early Programs
CD38 Inhibitor
Status: Phase: Lead Optimization
Undisclosed
Status: Phase: Target & Lead Discovery
BEACON+ platform
Status: Phase: Target & Lead Discovery
Join our team of experts.
Find Out More